Amyris, Inc. is an industrial biotechnology company headquartered in Emeryville, California, founded in 2003. The company specializes in synthetic biology, using precision fermentation and engineered microorganisms to convert plant sugars, primarily from sugarcane, into renewable molecules and specialty chemicals.
Amyris develops and manufactures bio-based ingredients for applications in cosmetics, personal care, flavors, fragrances, food, pharmaceuticals, and performance materials. Key products include farnesene-derived compounds such as squalane and squalene, as well as sweeteners like Reb M and biosilica. It operates advanced fermentation facilities, including plants in Brazil, to produce these sustainable alternatives to petroleum-based chemicals at commercial scale.
Initially focused on artemisinin for antimalarial drugs, Amyris has expanded into a vertically integrated platform for custom renewable chemistry, partnering with firms like WACKER on bio-based functional ingredients for cosmetics.
To provide comprehensive coverage, we aggregate data and news under the name Amyris, encompassing the following company names, divisions, and related entities:
Amyris Biotechnologies, Inc..
This list encompasses current and former names, alternate names, and key divisions associated with Amyris, ensuring you can easily find all relevant information under a single, unified profile.
